Helus Pharma appoints Michael Cola as CEO [Seeking Alpha]
Cybin Inc. (HELP)
Company Research
Source: Seeking Alpha
Cola's appointment comes at a pivotal moment as Helus advances its pipeline of next-generation mental health therapies toward key clinical and corporate value-inflection milestones, including the expected release of Phase 2 data for HLP004 this quarter and Phase 3 topline data for HLP003 in Q4 2026. More on Cybin Cybin 2026 Outlook: Clinical Milestones And Cash Position Set Stage For Momentum Cybin Inc. (CYBN) Q2 2026 Earnings Call Transcript Biggest stock movers Wednesday: Vanda Pharmaceuticals, Axsome Therapeutics and Cybin Psychedelics stocks could benefit from marijuana rescheduling: Jefferies Seeking Alpha's Quant Rating on Cybin Recommended For You More Trending News
Show less
Read more
Impact Snapshot
Event Time:
HELP
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
HELP alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
HELP alerts
High impacting Cybin Inc. news events
Weekly update
A roundup of the hottest topics
HELP
News
- Novel Serotonergic Agonists Positioned to Capture Share of $150B+ Neuropsychiatric MarketPR Newswire
- Helus Pharma Appoints Michael Cola as Chief Executive Officer to Lead Next Phase of Scale and ExecutionGlobeNewswire
- Cybin (NASDAQ:HELP) is now covered by analysts at Jefferies Financial Group Inc.. They set a "buy" rating and a $22.00 price target on the stock.MarketBeat
- Why Cybin (HELP) Is Down 9.1% After Rebranding To Helus And Relisting On Nasdaq [Yahoo! Finance]Yahoo! Finance
- HELUS Pharma Propels Therapeutic Innovation in Mental Health and Commences Trading on Nasdaq [Yahoo! Finance]Yahoo! Finance
HELP
Sec Filings
- 2/10/26 - Form 6-K
- 1/12/26 - Form D
- HELP's page on the SEC website